BBOTVSESYN• 12 Months (Normalized)
BBOT vs ESYN (BridgeBio Oncology Therapeutics Inc. vs EnerSyn Global Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.5
-72.07%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ESYN Performance $2.1
-18.29%
EnerSyn Global Inc.
Normalized Baseline0.00%
Alpha Spread Margin ESYN LEADS
-53.78 pts
ESYN outperforming by 53.78 percentage points
BBOTESYN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ESYN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BBOT Price | BBOT Gain (%) | ESYN Price | ESYN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.50 | -72.07% | $2.10 | -18.29% | -53.78% |
| Oct 05, 2026 | $3.60 | -71.27% | $2.12 | -17.51% | -53.76% |
| Oct 02, 2026 | $3.89 | -68.95% | $2.18 | -15.18% | -53.77% |
| Oct 01, 2026 | $- | $2.10 | -18.29% | - | |
| Sep 30, 2026 | $4.10 | -67.28% | $2.28 | -11.28% | -56.00% |
| Sep 29, 2026 | $3.92 | -68.72% | $2.32 | -9.92% | -58.80% |
| Sep 28, 2026 | $3.81 | -69.59% | $2.57 | +0.00% | -69.59% |
| Sep 25, 2026 | $3.95 | -68.48% | $- | - | |
| Sep 24, 2026 | $3.99 | -68.16% | $- | - | |
| Sep 23, 2026 | $4.16 | -66.80% | $- | - | |
| Sep 22, 2026 | $4.66 | -62.81% | $- | - | |
| Sep 21, 2026 | $4.66 | -62.81% | $- | - | |
| Sep 18, 2026 | $4.77 | -61.93% | $- | - | |
| Sep 17, 2026 | $4.89 | -60.97% | $- | - | |
| Sep 16, 2026 | $4.76 | -62.01% | $- | - |
Page 1 of 17